These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 25943556)
1. The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure. Stojcevski B; Celic V; Navarin S; Pencic B; Majstorovic A; Sljivic A; Magrini L; Cristofano F; Cavalieri L; Di Somma S; Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):676-684. PubMed ID: 25943556 [TBL] [Abstract][Full Text] [Related]
2. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels? Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618 [TBL] [Abstract][Full Text] [Related]
3. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study. Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696 [TBL] [Abstract][Full Text] [Related]
4. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score. Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162 [TBL] [Abstract][Full Text] [Related]
5. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure. Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322 [TBL] [Abstract][Full Text] [Related]
7. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months]. Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399 [TBL] [Abstract][Full Text] [Related]
8. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis. Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037 [TBL] [Abstract][Full Text] [Related]
9. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP. Leto L; Testa M; Feola M Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781 [TBL] [Abstract][Full Text] [Related]
10. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808 [TBL] [Abstract][Full Text] [Related]
11. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment. Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495 [TBL] [Abstract][Full Text] [Related]